REQUEST A DEMO
Total
USD $0.00
Search more companies

Sirio Pharma Co., Ltd (China)

Main Activities: Other Food Manufacturing
Full name: Sirio Pharma Co., Ltd Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Sirio Pharma Co., Ltd. is mainly engaged in research, development, manufacture, sale and technical services of nutrition and health food. The company's main products are soft capsules, vegetable gums, probiotics, soft candy, tablets, powders, hard capsules and health drinks. The company was founded in 1993 and is headquartered in Shantou City, China.

Headquarters
83 Taishan Road Shantou Guangdong
Shantou; Guangdong; Postal Code: 515057

Contact Details: Purchase the Sirio Pharma Co., Ltd report to view the information.

Website: http://www.siriopharma.com

Basic Information
Total Employees:
Purchase the Sirio Pharma Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Sirio Pharma Co., Ltd report to view the information.
Registered Capital:
Purchase the Sirio Pharma Co., Ltd report to view the information.
Financial Auditors:
Purchase the Sirio Pharma Co., Ltd report to view the information.
Incorporation Date:
August 16, 1993
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
43.08%
Purchase this report to view the information.
9.19%
Purchase this report to view the information.
7.47%
Purchase this report to view the information.
4%
Purchase this report to view the information.
3.55%
Subsidiaries
Ayanda GmbH
100%
Ayanda Verwaltungs GmbH
100%
Guangdong Heshi Biological Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Sirio Pharma Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
39.96%
Total operating revenue
38.49%
Operating profit (EBIT)
-5.99%
EBITDA
-5.65%
Net Profit (Loss) for the Period
-9.35%
Total assets
20.61%
Total equity
11.54%
Operating Profit Margin (ROS)
-3.86%
Net Profit Margin
-3.47%
Return on Equity (ROE)
-1.24%
Debt to Equity Ratio
-0.32%
Quick Ratio
-2.28%
Cash Ratio
-1.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?